BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Slavov SN, Maçonetto JDM, Martinez EZ, Silva-Pinto AC, Covas DT, Eis-Hübinger AM, Kashima S. Prevalence of hepatitis E virus infection in multiple transfused Brazilian patients with thalassemia and sickle cell disease. J Med Virol 2019;91:1693-7. [PMID: 31066064 DOI: 10.1002/jmv.25498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Cheung CKM, Wong SH, Law AWH, Law MF. Transfusion-transmitted hepatitis E: What we know so far? World J Gastroenterol 2022;28:47-75. [PMID: 35125819 DOI: 10.3748/wjg.v28.i1.47] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Farshadpour F, Taherkhani R, Shaeri M. Prevalence and risk factors of hepatitis E virus infection among patients with β-thalassemia major in South of Iran. Journal of Immunoassay and Immunochemistry. [DOI: 10.1080/15321819.2022.2046602] [Reference Citation Analysis]
3 Magri MC, Manchiero C, Dantas BP, da Silva Nunes AK, Figueiredo GM, Barone AA, Tengan FM. Hepatitis E virus seroprevalence in patients with chronic hepatitis C at a university hospital in Brazil. Future Virology 2020;15:791-9. [DOI: 10.2217/fvl-2020-0042] [Reference Citation Analysis]
4 Moraes DFDSD, Mesquita JR, Dutra V, Nascimento MSJ. Systematic Review of Hepatitis E Virus in Brazil: A One-Health Approach of the Human-Animal-Environment Triad. Animals (Basel) 2021;11:2290. [PMID: 34438747 DOI: 10.3390/ani11082290] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pourkarim MR. Hepatitis E Virus; An Underestimated Threat for the Viral Hepatitis Elimination Program. Hepat Mon 2022;22. [DOI: 10.5812/hepatmon-129678] [Reference Citation Analysis]